0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size, Status and Forecast 2020-2026
Published Date: April 2020
|
Report Code: QYRE-Othe-2O270
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
diagnostic radiopharmaceuticals and contrast media market

Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size, Status and Forecast 2020-2026

Code: QYRE-Othe-2O270
Report
April 2020
99 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
DIAGNOSTIC RADIOPHARMACEUTICALS & CONTRAST MEDIA MARKET OVERVIEW

 

The global Diagnostic Radiopharmaceuticals & Contrast Media market size was USD 8.326 billion in 2019 and is expected to hit USD 10.260 billion by the end of 2026, with a CAGR of 3.0 % in 2021-2026.

Radiopharmaceuticals are a group of pharmaceutical drugs which have radioactivity. The contrast media plays an important role in enhancing the imaging facilities for better diagnosis.

The market drivers are technology advancements in medical imaging, increasing demand for image-guided procedures and diagnostics and high prevalence of cancers and cardiac diseases.

 

GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS & CONTRAST MEDIA SCOPE AND MARKET SIZE

Diagnostic Radiopharmaceuticals & Contrast Media Market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Radiopharmaceuticals & Contrast Media market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Diagnostic Radiopharmaceuticals & Contrast Media market is segmented into Radiopharmaceuticals, Contrast Media, etc.

Segment by Application, the Diagnostic Radiopharmaceuticals & Contrast Media market is segmented into Diagnostic, Therapeutic, Ionizing Radiation based Radioimaging, Non-Ionizing Radiation based Radioimaging, etc.
Regional and Country-level Analysis

The Diagnostic Radiopharmaceuticals & Contrast Media market is analysed and market size information is provided by regions (countries).

The key regions covered in the Diagnostic Radiopharmaceuticals & Contrast Media market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

 

COMPETITIVE LANDSCAPE AND DIAGNOSTIC RADIOPHARMACEUTICALS & CONTRAST MEDIA MARKET SHARE ANALYSIS

Diagnostic Radiopharmaceuticals & Contrast Media market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Diagnostic Radiopharmaceuticals & Contrast Media business, the date to enter into the Diagnostic Radiopharmaceuticals & Contrast Media Market, Diagnostic Radiopharmaceuticals & Contrast Media product introduction, recent developments, etc.

The major vendors include Amag Pharmaceuticals, Bayer Healthcare, Bracco Imaging, Daiichi Sankyo, GE Healthcare, Guerbet, Lantheus, Mallinckrodt, Medtronic, Nordion, etc.

This report focuses on the global Diagnostic Radiopharmaceuticals & Contrast Media status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diagnostic Radiopharmaceuticals & Contrast Media development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

 

THE KEY PLAYERS COVERED IN THIS STUDY

  • Amag Pharmaceuticals
  • Bayer Healthcare
  • Bracco Imaging
  • Daiichi Sankyo
  • GE Healthcare
  • Guerbet
  • Lantheus
  • Mallinckrodt
  • Medtronic
  • Nordion

 

MARKET SEGMENT BY TYPE, THE PRODUCT CAN BE SPLIT INTO

  • Radiopharmaceuticals
  • Contrast Media

 

MARKET SEGMENT BY APPLICATION, SPLIT INTO

  • Diagnostic
  • Therapeutic
  • Ionizing Radiation based Radioimaging
  • Non-Ionizing Radiation based Radioimaging

 

MARKET SEGMENT BY REGIONS/COUNTRIES, THIS REPORT COVERS

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

 

THE STUDY OBJECTIVES OF THIS REPORT ARE:

  • To analyze global Diagnostic Radiopharmaceuticals & Contrast Media status, future forecast, growth opportunity, key market and key players.
  • To present the Diagnostic Radiopharmaceuticals & Contrast Media development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions

 

In this study, the years considered to estimate the market size of Diagnostic Radiopharmaceuticals & Contrast Media are as follows:

  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026


For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT:

 

1 Report Overview

    1.1 Study Scope

    1.2 Key Market Segments

    1.3 Players Covered: Ranking by Diagnostic Radiopharmaceuticals & Contrast Media Revenue

    1.4 Market Analysis by Type

        1.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Growth Rate by Type: 2020 VS 2026

        1.4.2 Radiopharmaceuticals

        1.4.3 Contrast Media

    1.5 Market by Application

        1.5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application: 2020 VS 2026

        1.5.2 Diagnostic

        1.5.3 Therapeutic

        1.5.4 Ionizing Radiation based Radioimaging

        1.5.5 Non-Ionizing Radiation based Radioimaging

    1.6 Study Objectives

    1.7 Years Considered

 

2 Global Growth Trends by Regions

    2.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Perspective (2015-2026)

    2.2 Diagnostic Radiopharmaceuticals & Contrast Media Growth Trends by Regions

        2.2.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Regions: 2015 VS 2020 VS 2026

        2.2.2 Diagnostic Radiopharmaceuticals & Contrast Media Historic Market Share by Regions (2015-2020)

        2.2.3 Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Market Size by Regions (2021-2026)

    2.3 Industry Trends and Growth Strategy

        2.3.1 Market Top Trends

        2.3.2 Market Drivers

        2.3.3 Market Challenges

        2.3.4 Porter’s Five Forces Analysis

        2.3.5 Diagnostic Radiopharmaceuticals & Contrast Media Market Growth Strategy

        2.3.6 Primary Interviews with Key Diagnostic Radiopharmaceuticals & Contrast Media Players (Opinion Leaders)

 

3 Competition Landscape by Key Players

    3.1 Global Top Diagnostic Radiopharmaceuticals & Contrast Media Players by Market Size

        3.1.1 Global Top Diagnostic Radiopharmaceuticals & Contrast Media Players by Revenue (2015-2020)

        3.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Players (2015-2020)

        3.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Concentration Ratio

        3.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Concentration Ratio (CR5 and HHI)

        3.2.2 Global Top 10 and Top 5 Companies by Diagnostic Radiopharmaceuticals & Contrast Media Revenue in 2019

    3.3 Diagnostic Radiopharmaceuticals & Contrast Media Key Players Head office and Area Served

    3.4 Key Players Diagnostic Radiopharmaceuticals & Contrast Media Product Solution and Service

    3.5 Date of Enter into Diagnostic Radiopharmaceuticals & Contrast Media Market

    3.6 Mergers & Acquisitions, Expansion Plans

 

4 Breakdown Data by Type (2015-2026)

    4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Historic Market Size by Type (2015-2020)

    4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Market Size by Type (2021-2026)

 

5 Diagnostic Radiopharmaceuticals & Contrast Media Breakdown Data by Application (2015-2026)

    5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)

    5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Market Size by Application (2021-2026)

 

6 North America

    6.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2015-2020)

    6.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Players in North America (2019-2020)

    6.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020)

    6.4 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)

 

7 Europe

    7.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2015-2020)

    7.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Players in Europe (2019-2020)

    7.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020)

    7.4 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)

 

8 China

    8.1 China Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2015-2020)

    8.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Players in China (2019-2020)

    8.3 China Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020)

    8.4 China Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)

 

9 Japan

    9.1 Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2015-2020)

    9.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Players in Japan (2019-2020)

    9.3 Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020)

    9.4 Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)

 

10 Southeast Asia

    10.1 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2015-2020)

    10.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Players in Southeast Asia (2019-2020)

    10.3 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020)

    10.4 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)

 

11 India

    11.1 India Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2015-2020)

    11.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Players in India (2019-2020)

    11.3 India Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020)

    11.4 India Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)

 

12 Central & South America

    12.1 Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2015-2020)

    12.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Players in Central & South America (2019-2020)

    12.3 Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020)

    12.4 Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020)

 

13 Key Players Profiles

    13.1 Amag Pharmaceuticals

        13.1.1 Amag Pharmaceuticals Company Details

        13.1.2 Amag Pharmaceuticals Business Overview and Its Total Revenue

        13.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Introduction

        13.1.4 Amag Pharmaceuticals Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020))

        13.1.5 Amag Pharmaceuticals Recent Development

    13.2 Bayer Healthcare

        13.2.1 Bayer Healthcare Company Details

        13.2.2 Bayer Healthcare Business Overview and Its Total Revenue

        13.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Introduction

        13.2.4 Bayer Healthcare Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

        13.2.5 Bayer Healthcare Recent Development

    13.3 Bracco Imaging

        13.3.1 Bracco Imaging Company Details

        13.3.2 Bracco Imaging Business Overview and Its Total Revenue

        13.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Introduction

        13.3.4 Bracco Imaging Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

        13.3.5 Bracco Imaging Recent Development

    13.4 Daiichi Sankyo

        13.4.1 Daiichi Sankyo Company Details

        13.4.2 Daiichi Sankyo Business Overview and Its Total Revenue

        13.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Introduction

        13.4.4 Daiichi Sankyo Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

        13.4.5 Daiichi Sankyo Recent Development

    13.5 GE Healthcare

        13.5.1 GE Healthcare Company Details

        13.5.2 GE Healthcare Business Overview and Its Total Revenue

        13.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Introduction

        13.5.4 GE Healthcare Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

        13.5.5 GE Healthcare Recent Development

    13.6 Guerbet

        13.6.1 Guerbet Company Details

        13.6.2 Guerbet Business Overview and Its Total Revenue

        13.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Introduction

        13.6.4 Guerbet Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

        13.6.5 Guerbet Recent Development

    13.7 Lantheus

        13.7.1 Lantheus Company Details

        13.7.2 Lantheus Business Overview and Its Total Revenue

        13.7.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Introduction

        13.7.4 Lantheus Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

        13.7.5 Lantheus Recent Development

    13.8 Mallinckrodt

        13.8.1 Mallinckrodt Company Details

        13.8.2 Mallinckrodt Business Overview and Its Total Revenue

        13.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Introduction

        13.8.4 Mallinckrodt Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

        13.8.5 Mallinckrodt Recent Development

    13.9 Medtronic

        13.9.1 Medtronic Company Details

        13.9.2 Medtronic Business Overview and Its Total Revenue

        13.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Introduction

        13.9.4 Medtronic Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

        13.9.5 Medtronic Recent Development

    13.10 Nordion

        13.10.1 Nordion Company Details

        13.10.2 Nordion Business Overview and Its Total Revenue

        13.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Introduction

        13.10.4 Nordion Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

        13.10.5 Nordion Recent Development

 

14 Analyst's Viewpoints/Conclusions

 

15 Appendix

    15.1 Research Methodology

        15.1.1 Methodology/Research Approach

        15.1.2 Data Source

    15.2 Disclaimer

    15.3 Author Details

LIST OF TABLES & FIGURES :

 

 

Table 1. Diagnostic Radiopharmaceuticals & Contrast Media Key Market Segments

Table 2. Key Players Covered: Ranking by Diagnostic Radiopharmaceuticals & Contrast Media Revenue

Table 3. Ranking of Global Top Diagnostic Radiopharmaceuticals & Contrast Media Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Radiopharmaceuticals

Table 6. Key Players of Contrast Media

Table 7. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 8. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Regions (US$ Million): 2020 VS 2026

Table 9. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Regions (2015-2020) (US$ Million)

Table 10. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Regions (2015-2020)

Table 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 12. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Regions (2021-2026)

Table 13. Market Top Trends

Table 14. Key Drivers: Impact Analysis

Table 15. Key Challenges

Table 16. Diagnostic Radiopharmaceuticals & Contrast Media Market Growth Strategy

Table 17. Main Points Interviewed from Key Diagnostic Radiopharmaceuticals & Contrast Media Players

Table 18. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Players (2015-2020) (Million US$)

Table 19. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Players (2015-2020)

Table 20. Global Top Diagnostic Radiopharmaceuticals & Contrast Media Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Radiopharmaceuticals & Contrast Media as of 2019)

Table 21. Global Diagnostic Radiopharmaceuticals & Contrast Media by Players Market Concentration Ratio (CR5 and HHI)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Diagnostic Radiopharmaceuticals & Contrast Media Product Solution and Service

Table 24. Date of Enter into Diagnostic Radiopharmaceuticals & Contrast Media Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)

Table 27. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Share by Type (2015-2020)

Table 28. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2021-2026)

Table 29. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Share by Application (2015-2020)

Table 30. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)

Table 31. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Share by Application (2021-2026)

Table 32. North America Key Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2019-2020) (Million US$)

Table 33. North America Key Players Diagnostic Radiopharmaceuticals & Contrast Media Market Share (2019-2020)

Table 34. North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)

Table 35. North America Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type (2015-2020)

Table 36. North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)

Table 37. North America Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application (2015-2020)

Table 38. Europe Key Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2019-2020) (Million US$)

Table 39. Europe Key Players Diagnostic Radiopharmaceuticals & Contrast Media Market Share (2019-2020)

Table 40. Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)

Table 41. Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type (2015-2020)

Table 42. Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)

Table 43. Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application (2015-2020)

Table 44. China Key Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2019-2020) (Million US$)

Table 45. China Key Players Diagnostic Radiopharmaceuticals & Contrast Media Market Share (2019-2020)

Table 46. China Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)

Table 47. China Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type (2015-2020)

Table 48. China Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)

Table 49. China Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application (2015-2020)

Table 50. Japan Key Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2019-2020) (Million US$)

Table 51. Japan Key Players Diagnostic Radiopharmaceuticals & Contrast Media Market Share (2019-2020)

Table 52. Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)

Table 53. Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type (2015-2020)

Table 54. Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)

Table 55. Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application (2015-2020)

Table 56. Southeast Asia Key Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2019-2020) (Million US$)

Table 57. Southeast Asia Key Players Diagnostic Radiopharmaceuticals & Contrast Media Market Share (2019-2020)

Table 58. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)

Table 59. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type (2015-2020)

Table 60. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)

Table 61. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application (2015-2020)

Table 62. India Key Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2019-2020) (Million US$)

Table 63. India Key Players Diagnostic Radiopharmaceuticals & Contrast Media Market Share (2019-2020)

Table 64. India Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)

Table 65. India Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type (2015-2020)

Table 66. India Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)

Table 67. India Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application (2015-2020)

Table 68. Central & South America Key Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2019-2020) (Million US$)

Table 69. Central & South America Key Players Diagnostic Radiopharmaceuticals & Contrast Media Market Share (2019-2020)

Table 70. Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type (2015-2020) (Million US$)

Table 71. Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type (2015-2020)

Table 72. Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application (2015-2020) (Million US$)

Table 73. Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application (2015-2020)

Table 74. Amag Pharmaceuticals Company Details

Table 75. Amag Pharmaceuticals Business Overview

Table 76. Amag Pharmaceuticals Product

Table 77. Amag Pharmaceuticals Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)

Table 78. Amag Pharmaceuticals Recent Development

Table 79. Bayer Healthcare Company Details

Table 80. Bayer Healthcare Business Overview

Table 81. Bayer Healthcare Product

Table 82. Bayer Healthcare Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)

Table 83. Bayer Healthcare Recent Development

Table 84. Bracco Imaging Company Details

Table 85. Bracco Imaging Business Overview

Table 86. Bracco Imaging Product

Table 87. Bracco Imaging Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)

Table 88. Bracco Imaging Recent Development

Table 89. Daiichi Sankyo Company Details

Table 90. Daiichi Sankyo Business Overview

Table 91. Daiichi Sankyo Product

Table 92. Daiichi Sankyo Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)

Table 93. Daiichi Sankyo Recent Development

Table 94. GE Healthcare Company Details

Table 95. GE Healthcare Business Overview

Table 96. GE Healthcare Product

Table 97. GE Healthcare Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)

Table 98. GE Healthcare Recent Development

Table 99. Guerbet Company Details

Table 100. Guerbet Business Overview

Table 101. Guerbet Product

Table 102. Guerbet Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)

Table 103. Guerbet Recent Development

Table 104. Lantheus Company Details

Table 105. Lantheus Business Overview

Table 106. Lantheus Product

Table 107. Lantheus Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)

Table 108. Lantheus Recent Development

Table 109. Mallinckrodt Business Overview

Table 110. Mallinckrodt Product

Table 111. Mallinckrodt Company Details

Table 112. Mallinckrodt Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)

Table 113. Mallinckrodt Recent Development

Table 114. Medtronic Company Details

Table 115. Medtronic Business Overview

Table 116. Medtronic Product

Table 117. Medtronic Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)

Table 118. Medtronic Recent Development

Table 119. Nordion Company Details

Table 120. Nordion Business Overview

Table 121. Nordion Product

Table 122. Nordion Revenue in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020) (Million US$)

Table 123. Nordion Recent Development

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type: 2020 VS 2026

Figure 2. Radiopharmaceuticals Features

Figure 3. Contrast Media Features

Figure 4. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application: 2020 VS 2026

Figure 5. Diagnostic Case Studies

Figure 6. Therapeutic Case Studies

Figure 7. Ionizing Radiation based Radioimaging Case Studies

Figure 8. Non-Ionizing Radiation based Radioimaging Case Studies

Figure 9. Diagnostic Radiopharmaceuticals & Contrast Media Report Years Considered

Figure 10. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth 2015-2026 (US$ Million)

Figure 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Regions: 2020 VS 2026

Figure 12. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Regions (2021-2026)

Figure 13. Porter's Five Forces Analysis

Figure 14. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Players in 2019

Figure 15. Global Top Diagnostic Radiopharmaceuticals & Contrast Media Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Radiopharmaceuticals & Contrast Media as of 2019

Figure 16. The Top 10 and 5 Players Market Share by Diagnostic Radiopharmaceuticals & Contrast Media Revenue in 2019

Figure 17. North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth (2015-2020) (Million US$)

Figure 18. Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth (2015-2020) (Million US$)

Figure 19. China Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. India Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Central & South America Diagnostic Radiopharmaceuticals & Contrast Media Market Size YoY Growth (2015-2020) (Million US$)

Figure 24. Amag Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 25. Amag Pharmaceuticals Revenue Growth Rate in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

Figure 26. Bayer Healthcare Total Revenue (US$ Million): 2019 Compared with 2018

Figure 27. Bayer Healthcare Revenue Growth Rate in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

Figure 28. Bracco Imaging Total Revenue (US$ Million): 2019 Compared with 2018

Figure 29. Bracco Imaging Revenue Growth Rate in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

Figure 30. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018

Figure 31. Daiichi Sankyo Revenue Growth Rate in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

Figure 32. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018

Figure 33. GE Healthcare Revenue Growth Rate in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

Figure 34. Guerbet Total Revenue (US$ Million): 2019 Compared with 2018

Figure 35. Guerbet Revenue Growth Rate in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

Figure 36. Lantheus Total Revenue (US$ Million): 2019 Compared with 2018

Figure 37. Lantheus Revenue Growth Rate in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

Figure 38. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018

Figure 39. Mallinckrodt Revenue Growth Rate in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

Figure 40. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018

Figure 41. Medtronic Revenue Growth Rate in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

Figure 42. Nordion Total Revenue (US$ Million): 2019 Compared with 2018

Figure 43. Nordion Revenue Growth Rate in Diagnostic Radiopharmaceuticals & Contrast Media Business (2015-2020)

Figure 44. Bottom-up and Top-down Approaches for This Report

Figure 45. Data Triangulation

Figure 46. Key Executives Interviewed

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$7800
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global and Japan qPCR Kits Market Insights Forecast to 2027
Global and Japan qPCR Kits Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-39Y7542
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Human ELISA Kits Market Insights Forecast to 2027
Global and China Human ELISA Kits Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-24Z7484
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and United States PCR Amplifier Market Insights Forecast to 2027
Global and United States PCR Amplifier Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-6W7895
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Porcine ELISA Kits Market Insights Forecast to 2027
Global and China Porcine ELISA Kits Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-37N7620
Wed Nov 24 00:00:00 UTC 2021

Add to Cart